Health ❯ Healthcare ❯ Medical Research ❯ Clinical Trials

Immunotherapy

Treating Advanced Lung Cancer Before 3 p.m. Extends Survival in Phase III Trial

Investigators urge trials to document infusion time to probe a circadian immune effect.

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors